S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
The 1 Stock To Watch In This Market. (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
The 1 Stock To Watch In This Market. (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
The 1 Stock To Watch In This Market. (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
The 1 Stock To Watch In This Market. (Ad)pixel
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NASDAQ:CRVS

Corvus Pharmaceuticals - CRVS Earnings Date, Estimates & Call Transcripts

$0.68
-0.02 (-2.86%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.68
▼
$0.70
50-Day Range
$0.65
▼
$0.91
52-Week Range
$0.61
▼
$2.11
Volume
34,457 shs
Average Volume
97,569 shs
Market Capitalization
$31.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CRVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Corvus Pharmaceuticals Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.92 EPS
Next Year EPS Consensus Estimate: $-0.69 EPS

CRVS Earnings Date and Information

Corvus Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, March 28th, 2023. Corvus Pharmaceuticals will be holding an earnings conference call on Tuesday, March 28th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Corvus Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/28/2023
(Confirmed)		         
11/3/2022Q3 2022($0.32)($0.32)($0.32)  
8/8/2022Q2 2022($0.19)($0.18)+$0.01($0.18)
5/5/2022Q1 2022($0.14)($0.18)($0.04)($0.18)  
3/10/2022Q4 2021($0.20)($0.20)($0.20)    
10/31/20219/30/2021($0.24)($0.24)($0.24)
8/1/20216/30/2021($0.32)($0.28)+$0.04($0.28)
4/29/20213/31/2021($0.33)($0.34)($0.01)($0.34)
3/24/202112/31/2020($0.32)$0.92+$1.24($1.62)
10/29/20209/30/2020($0.24)($0.33)($0.09)($0.33)
7/30/20206/30/2020($0.28)($0.36)($0.08)($0.36)  
4/30/20203/31/2020($0.40)($0.44)($0.04)($0.44)  
3/5/202012/31/2019($0.33)($0.38)($0.05)($0.38)  
10/29/2019Q3 2019($0.42)($0.37)+$0.05($0.37)  
8/1/2019Q2 2019($0.42)($0.44)($0.02)($0.44)  
5/9/2019Q1($0.40)($0.40)($0.40)  
3/7/2019Q4($0.4630)($0.36)+$0.1030($0.36)
11/1/2018Q3($0.4760)($0.36)+$0.1160($0.36)
8/2/2018Q2 2018($0.6450)($0.40)+$0.2450($0.40)
5/3/2018Q1 2018($0.7360)($0.63)+$0.1060($0.63)
3/1/2018Q4 2017($0.7650)($0.58)+$0.1850($0.58)
11/2/2017Q3 2017($0.8140)($0.62)+$0.1940($0.62)
8/3/2017Q2 2017($0.76)($0.73)+$0.03($0.73)
5/4/2017Q1 2017($0.79)($0.79)($0.79)
3/10/201712/31/2016($0.52)($0.55)($0.03)($0.55)
11/3/2016Q3 2016($0.45)($0.51)($0.06)($0.51)
8/4/2016Q2 2016($0.36)($0.43)($0.07)($0.43)
5/5/2016Q1 2016($5.39)($5.39)($5.39)












Corvus Pharmaceuticals Earnings - Frequently Asked Questions

When is Corvus Pharmaceuticals's earnings date?

Corvus Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, March 28th, 2023. Learn more on CRVS's earnings history.

How much profit does Corvus Pharmaceuticals generate each year?

Corvus Pharmaceuticals (NASDAQ:CRVS) has a recorded net income of -$43.24 million. CRVS has generated -$0.88 earnings per share over the last four quarters.

What is Corvus Pharmaceuticals's EPS forecast for next year?

Corvus Pharmaceuticals's earnings are expected to grow from ($0.92) per share to ($0.69) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:CRVS) was last updated on 3/24/2023 by MarketBeat.com Staff